A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH
NCT02855892
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
161
Enrollment
INDUSTRY
Sponsor class
Conditions
Benign Prostatic Hyperplasia (BPH)
Interventions
OTHER:
Placebo
DRUG:
GV1001
Sponsor
GemVax & Kael